Kelun-Biotech Advances SKB575 with China IND Approval
CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...
MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...
